Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen

Resistance to Targeted Therapies in Breast Cancer

This book will provide an in-depth description of resistance to targeted therapies in breast cancer This book will discuss targeted therapies used to treat ER+ or Her2+ breast cancers (i.e. Tamoxifen or trastuzumab) This book will also discuss targeting signaling pathways activated in triple negative breast cancer (i.e. EGFR and Wnt signaling) This book will give insight into the landscape of breast cancer treatment and the challenges of targeted therapy This book will provide a glimpse into the future of breast cancer therapy
EAN: 9783319888910
Sprache: Englisch
Seitenzahl: 200
Produktart: kartoniert, broschiert
Herausgeber: Prosperi, Jenifer R.
Verlag: Springer International Publishing
Veröffentlichungsdatum: 23.06.2018
Größe: 12 × 155 × 235
Gewicht: 312 g

Verwandte Artikel

Resistance to Targeted Therapies in Breast Cancer
179,00 €*
inkl. MwSt, zzgl. Versand